Business Wire

Amundi Intermédiation Selects FlexTrade for Multi-Asset Execution Management

26.7.2023 11:25:00 EEST | Business Wire | Press release

Share

FlexTrade Systems, a global leader in multi-asset execution and order management systems, today announced that European execution platform leader, Amundi Intermédiation, has selected FlexTRADER EMS to consolidate all asset classes traded onto a single, scalable, multi-asset EMS platform. Amundi Intermédiation, the execution business subsidiary of Amundi Asset Management, additionally acts as an outsourced execution provider for Asset Managers, Private Banking, and Insurance companies, which globally executes approximately €5 trillion across all asset classes for around 60 clients.

Consolidation of front office technology and automation initiatives are currently in sharp focus for global buy-side institutions to streamline and optimize execution workflows in equities and extend the efficiencies to other asset classes, including fixed income.

FlexTrade’s FlexTRADER EMS solution will be deployed as Amundi Intermédiation’s global, centralized EMS platform to deliver cross-asset trading capabilities to over 60 dealers within its international investment hubs across trading desks in Paris, Dublin, Singapore and Tokyo. The move is designed to deliver dealers a common, robust set of tools and processes to handle cross-asset trading and execution efficiently.

Further, by deploying FlexTRADER EMS, Amundi Intermédiation’s dealing teams will benefit from sophisticated automation tools to streamline order and workflow management through FlexAlgowheel across all asset classes, enabling the firm to scale up its trading volumes alongside business growth efficiently.

With the move to deploy FlexTRADER EMS, Amundi Intermédiation will use FlexTrade’s unique fixed-income capabilities to bring more automation and electronification to their bond executing operations. Amundi Intermédiation will replace existing multi-platform processes through a single fixed-income EMS and deliver an aggregated view of the market and bilateral connectivity to liquidity providers. Further, using FlexTrade’s Fixed Income Smart Order Router (FISOR), its bond dealers can enrich their automation capabilities using consolidated pre-trade data to ensure best execution.

The project will be delivered in multiple phases, with equities and derivatives now live and in production across Amundi Intermédiation’s global trading desks. Fixed income will be deployed by the end of the year 2023.

Andy Mahoney, Managing Director, EMEA at FlexTrade, noted: “We are delighted to welcome Europe’s largest execution platform to FlexTrade. Proactively choosing to consolidate onto a single platform is a strategic vision to ensure Amundi Intermédiation’s execution operations have the core trading technology platform its businesses need to deliver the best outcomes to its clients. Notably, Amundi Intermédiation will also leverage our fixed-income capabilities, further validating the growing trend in the market to electronify bond trading activities.”

About FlexTrade Systems:

FlexTrade Systems is a global leader in high performance multi-asset execution management and order management systems for equities, fixed income, foreign exchange, futures, and options. A pioneer in the field, FlexTrade is internationally recognized for introducing FlexTRADER®, the world’s first broker-neutral, execution management trading system, which allows clients to completely control and customize their execution workflows through a comprehensive ability to search/access liquidity while maintaining the confidentiality of their trading strategies.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Iain Smith
Iain.Smith@FlexTrade.com
o: +44 (0)20 3757 9311

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SMBC and Toshiba Jointly Develop New Equity Indices Using Advanced Quantum-Driven Technologies28.5.2026 04:00:00 EEST | Press release

Sumitomo Mitsui Banking Corporation (“SMBC”) and Toshiba Corporation (“Toshiba”) today announced the joint development of the SMBC/TOSHIBA Quantum Driven Diversified Japan Equity Index and the SMBC/TOSHIBA Quantum Driven Diversified U.S. Equity Index, new equity indices realized with advanced quantum-driven technologies. Collectively, the indices are referred to as “SMBC/TOSHIBA Quantum Diversified” (the “Indices”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519448161/en/ Toshiba’s Simulated Bifurcation Machine 1. Background and Objectives Equity investment is central to asset management, but it also carries the ever-present risk of abrupt and substantial market fluctuations driven by geopolitical developments, changes in economic policy, and other external factors. In uncertain markets, investors are constantly seeking innovations in risk diversification that can protect their assets from unexpected market shocks. SM

BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 202628.5.2026 00:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from HERIZON-GEA-01 were published in The New England Journal of Medicine and will be presented in an oral presentation (Rapid Oral Abstract: 4010) at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2026, in Chicago.The HERIZON-GEA-01 clinical trial evaluated ZIIHERA® (zanidatamab) plus chemotherapy, with and without TEVIMBRA® (tislelizumab), compared with the control arm of trastuzumab plus chemotherapy as first-line treatment for advanced/metastatic HER2+ gastroesophageal adenocarcinoma (GEA). Dr. Sun Young Rha, Professor of Medical Oncology at the Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea, senior author of the NEJM manuscript and first author of the ASCO abstract, said: “Results from the HERIZON-GEA-01 published in The New England Journal of Medicine and presented in an oral presentation at ASCO provide ne

Stallergenes Greer Foundation Celebrates Excellence in Allergy Innovation With 2025 Awards27.5.2026 18:22:00 EEST | Press release

The Stallergenes Greer Foundation, dedicated to advancing allergy research, fostering innovation and addressing environmental factors which impact allergies, is delighted to announce the recipients of the 2025 edition of its prestigious Science Awards for Allergy. Building on the success of the previous edition, this year’s awards recognise outstanding contributions to allergy research and patient engagement and allocate a total of €100,000 to support these initiatives. Four researchers have been selected by the Board as award recipients, each receiving €25,000 across two categories: Innovation In Treatment Awards Assoc. Professor Alexander Eggel, PhD, Department for Biomedical Research, University of Bern, and Department of Rheumatology and Immunology, University Hospital Bern, Switzerland, recognised for his research: “Improving diagnostic and therapeutic options for allergic patients”; Dr Janice A. Layhadi, PhD, Research Associate, National Heart and Lung Institute, Imperial College

Capchase Secures $200M+, as Demand for Vendor Financing in Enterprise Tech Deals Accelerates27.5.2026 17:00:00 EEST | Press release

Capchase, the leading vendor financing platform for enterprise tech, today announced $200M+ in incremental funding to scale its embedded financing infrastructure globally and deploy more AI-enabled features. The funding, a mix of debt warehouse facilities and equity backed by institutional investors, reflects market validation that vendor financing has become essential infrastructure for enterprise technology companies to sell hardware and software products. As global B2B buyers face tighter budgets and greater scrutiny over large, up-front purchases, financing demand is growing. The Market Shift: Financing as a Growth Lever for B2B Tech Companies The $1.3 trillion vendor financing market has been traditionally dominated by banks and other lenders that utilize multi-thread email chains to manual doc review for underwriting. Capchase replaces those bottlenecks with financing tech embedded directly into sales tools such as Salesforce, enabling 97% of lending applications to be vetted and

ClickHouse Tops $250M ARR and 4,000 Customers, Launches Claude-Powered Agents at Open House 202627.5.2026 16:00:00 EEST | Press release

ClickHouse today opened Open House 2026, its second annual user conference, with a set of announcements that mark one of the company's most active quarters since founding. ClickHouse’s serverless cloud offering has crossed over $250 million in annual run-rate revenue — more than triple a year ago — and added more than 1,000 net new customers since January, bringing its total to 4,000. To meet the demands of AI-era workloads, the company also launched ClickHouse Agents, a fully managed agentic analytics service powered by Anthropic's Claude; published CostBench, an open benchmark comparing the major cloud data warehouses on cost-performance; and introduced House Mates, its first formal partner program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527813115/en/ ClickHouse Co-Founders (left to right): Yury Izrailevsky, Aaron Katz, Alexey Milovidov Growth When ClickHouse closed its $400 million Series D in January 2026, it

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye